Cargando…

The female syndecan-4(−/−) heart has smaller cardiomyocytes, augmented insulin/pSer473-Akt/pSer9-GSK-3β signaling, and lowered SCOP, pThr308-Akt/Akt and GLUT4 levels

Background: In cardiac muscle, the ubiquitously expressed proteoglycan syndecan-4 is involved in the hypertrophic response to pressure overload. Protein kinase Akt signaling, which is known to regulate hypertrophy, has been found to be reduced in the cardiac muscle of exercised male syndecan-4(−/−)...

Descripción completa

Detalles Bibliográficos
Autores principales: Støle, Thea Parsberg, Lunde, Marianne, Shen, Xin, Martinsen, Marita, Lunde, Per Kristian, Li, Jia, Lockwood, Francesca, Sjaastad, Ivar, Louch, William Edward, Aronsen, Jan Magnus, Christensen, Geir, Carlson, Cathrine Rein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452846/
https://www.ncbi.nlm.nih.gov/pubmed/36092718
http://dx.doi.org/10.3389/fcell.2022.908126
_version_ 1784785005773324288
author Støle, Thea Parsberg
Lunde, Marianne
Shen, Xin
Martinsen, Marita
Lunde, Per Kristian
Li, Jia
Lockwood, Francesca
Sjaastad, Ivar
Louch, William Edward
Aronsen, Jan Magnus
Christensen, Geir
Carlson, Cathrine Rein
author_facet Støle, Thea Parsberg
Lunde, Marianne
Shen, Xin
Martinsen, Marita
Lunde, Per Kristian
Li, Jia
Lockwood, Francesca
Sjaastad, Ivar
Louch, William Edward
Aronsen, Jan Magnus
Christensen, Geir
Carlson, Cathrine Rein
author_sort Støle, Thea Parsberg
collection PubMed
description Background: In cardiac muscle, the ubiquitously expressed proteoglycan syndecan-4 is involved in the hypertrophic response to pressure overload. Protein kinase Akt signaling, which is known to regulate hypertrophy, has been found to be reduced in the cardiac muscle of exercised male syndecan-4(−/−) mice. In contrast, we have recently found that pSer473-Akt signaling is elevated in the skeletal muscle (tibialis anterior, TA) of female syndecan-4(−/−) mice. To determine if the differences seen in Akt signaling are sex specific, we have presently investigated Akt signaling in the cardiac muscle of sedentary and exercised female syndecan-4(−/−) mice. To get deeper insight into the female syndecan-4(−/−) heart, alterations in cardiomyocyte size, a wide variety of different extracellular matrix components, well-known syndecan-4 binding partners and associated signaling pathways have also been investigated. Methods: Left ventricles (LVs) from sedentary and exercise trained female syndecan-4(−/−) and WT mice were analyzed by immunoblotting and real-time PCR. Cardiomyocyte size and phosphorylated Ser473-Akt were analyzed in isolated adult cardiomyocytes from female syndecan-4(−/−) and WT mice by confocal imaging. LV and skeletal muscle (TA) from sedentary male syndecan-4(−/−) and WT mice were immunoblotted with Akt antibodies for comparison. Glucose levels were measured by a glucometer, and fasting blood serum insulin and C-peptide levels were measured by ELISA. Results: Compared to female WT hearts, sedentary female syndecan-4(−/−) LV cardiomyocytes were smaller and hearts had higher levels of pSer473-Akt and its downstream target pSer9-GSK-3β. The pSer473-Akt inhibitory phosphatase PHLPP1/SCOP was lowered, which may be in response to the elevated serum insulin levels found in the female syndecan-4(−/−) mice. We also observed lowered levels of pThr308-Akt/Akt and GLUT4 in the female syndecan-4(−/−) heart and an increased LRP6 level after exercise. Otherwise, few alterations were found. The pThr308-Akt and pSer473-Akt levels were unaltered in the cardiac and skeletal muscles of sedentary male syndecan-4(−/−) mice. Conclusion: Our data indicate smaller cardiomyocytes, an elevated insulin/pSer473-Akt/pSer9-GSK-3β signaling pathway, and lowered SCOP, pThr308-Akt/Akt and GLUT4 levels in the female syndecan-4(−/−) heart. In contrast, cardiomyocyte size, and Akt signaling were unaltered in both cardiac and skeletal muscles from male syndecan-4(−/−) mice, suggesting important sex differences.
format Online
Article
Text
id pubmed-9452846
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94528462022-09-09 The female syndecan-4(−/−) heart has smaller cardiomyocytes, augmented insulin/pSer473-Akt/pSer9-GSK-3β signaling, and lowered SCOP, pThr308-Akt/Akt and GLUT4 levels Støle, Thea Parsberg Lunde, Marianne Shen, Xin Martinsen, Marita Lunde, Per Kristian Li, Jia Lockwood, Francesca Sjaastad, Ivar Louch, William Edward Aronsen, Jan Magnus Christensen, Geir Carlson, Cathrine Rein Front Cell Dev Biol Cell and Developmental Biology Background: In cardiac muscle, the ubiquitously expressed proteoglycan syndecan-4 is involved in the hypertrophic response to pressure overload. Protein kinase Akt signaling, which is known to regulate hypertrophy, has been found to be reduced in the cardiac muscle of exercised male syndecan-4(−/−) mice. In contrast, we have recently found that pSer473-Akt signaling is elevated in the skeletal muscle (tibialis anterior, TA) of female syndecan-4(−/−) mice. To determine if the differences seen in Akt signaling are sex specific, we have presently investigated Akt signaling in the cardiac muscle of sedentary and exercised female syndecan-4(−/−) mice. To get deeper insight into the female syndecan-4(−/−) heart, alterations in cardiomyocyte size, a wide variety of different extracellular matrix components, well-known syndecan-4 binding partners and associated signaling pathways have also been investigated. Methods: Left ventricles (LVs) from sedentary and exercise trained female syndecan-4(−/−) and WT mice were analyzed by immunoblotting and real-time PCR. Cardiomyocyte size and phosphorylated Ser473-Akt were analyzed in isolated adult cardiomyocytes from female syndecan-4(−/−) and WT mice by confocal imaging. LV and skeletal muscle (TA) from sedentary male syndecan-4(−/−) and WT mice were immunoblotted with Akt antibodies for comparison. Glucose levels were measured by a glucometer, and fasting blood serum insulin and C-peptide levels were measured by ELISA. Results: Compared to female WT hearts, sedentary female syndecan-4(−/−) LV cardiomyocytes were smaller and hearts had higher levels of pSer473-Akt and its downstream target pSer9-GSK-3β. The pSer473-Akt inhibitory phosphatase PHLPP1/SCOP was lowered, which may be in response to the elevated serum insulin levels found in the female syndecan-4(−/−) mice. We also observed lowered levels of pThr308-Akt/Akt and GLUT4 in the female syndecan-4(−/−) heart and an increased LRP6 level after exercise. Otherwise, few alterations were found. The pThr308-Akt and pSer473-Akt levels were unaltered in the cardiac and skeletal muscles of sedentary male syndecan-4(−/−) mice. Conclusion: Our data indicate smaller cardiomyocytes, an elevated insulin/pSer473-Akt/pSer9-GSK-3β signaling pathway, and lowered SCOP, pThr308-Akt/Akt and GLUT4 levels in the female syndecan-4(−/−) heart. In contrast, cardiomyocyte size, and Akt signaling were unaltered in both cardiac and skeletal muscles from male syndecan-4(−/−) mice, suggesting important sex differences. Frontiers Media S.A. 2022-08-25 /pmc/articles/PMC9452846/ /pubmed/36092718 http://dx.doi.org/10.3389/fcell.2022.908126 Text en Copyright © 2022 Støle, Lunde, Shen, Martinsen, Lunde, Li, Lockwood, Sjaastad, Louch, Aronsen, Christensen and Carlson. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Støle, Thea Parsberg
Lunde, Marianne
Shen, Xin
Martinsen, Marita
Lunde, Per Kristian
Li, Jia
Lockwood, Francesca
Sjaastad, Ivar
Louch, William Edward
Aronsen, Jan Magnus
Christensen, Geir
Carlson, Cathrine Rein
The female syndecan-4(−/−) heart has smaller cardiomyocytes, augmented insulin/pSer473-Akt/pSer9-GSK-3β signaling, and lowered SCOP, pThr308-Akt/Akt and GLUT4 levels
title The female syndecan-4(−/−) heart has smaller cardiomyocytes, augmented insulin/pSer473-Akt/pSer9-GSK-3β signaling, and lowered SCOP, pThr308-Akt/Akt and GLUT4 levels
title_full The female syndecan-4(−/−) heart has smaller cardiomyocytes, augmented insulin/pSer473-Akt/pSer9-GSK-3β signaling, and lowered SCOP, pThr308-Akt/Akt and GLUT4 levels
title_fullStr The female syndecan-4(−/−) heart has smaller cardiomyocytes, augmented insulin/pSer473-Akt/pSer9-GSK-3β signaling, and lowered SCOP, pThr308-Akt/Akt and GLUT4 levels
title_full_unstemmed The female syndecan-4(−/−) heart has smaller cardiomyocytes, augmented insulin/pSer473-Akt/pSer9-GSK-3β signaling, and lowered SCOP, pThr308-Akt/Akt and GLUT4 levels
title_short The female syndecan-4(−/−) heart has smaller cardiomyocytes, augmented insulin/pSer473-Akt/pSer9-GSK-3β signaling, and lowered SCOP, pThr308-Akt/Akt and GLUT4 levels
title_sort female syndecan-4(−/−) heart has smaller cardiomyocytes, augmented insulin/pser473-akt/pser9-gsk-3β signaling, and lowered scop, pthr308-akt/akt and glut4 levels
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452846/
https://www.ncbi.nlm.nih.gov/pubmed/36092718
http://dx.doi.org/10.3389/fcell.2022.908126
work_keys_str_mv AT støletheaparsberg thefemalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT lundemarianne thefemalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT shenxin thefemalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT martinsenmarita thefemalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT lundeperkristian thefemalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT lijia thefemalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT lockwoodfrancesca thefemalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT sjaastadivar thefemalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT louchwilliamedward thefemalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT aronsenjanmagnus thefemalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT christensengeir thefemalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT carlsoncathrinerein thefemalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT støletheaparsberg femalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT lundemarianne femalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT shenxin femalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT martinsenmarita femalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT lundeperkristian femalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT lijia femalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT lockwoodfrancesca femalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT sjaastadivar femalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT louchwilliamedward femalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT aronsenjanmagnus femalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT christensengeir femalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels
AT carlsoncathrinerein femalesyndecan4hearthassmallercardiomyocytesaugmentedinsulinpser473aktpser9gsk3bsignalingandloweredscoppthr308aktaktandglut4levels